Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1657

TAZAROTENE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1

Basic Information

ChEMBL ID CHEMBL1657
Name TAZAROTENE
Phase Approved
Structure Type MOL
InChI Key OGQICQVSFDPSEI-UHFFFAOYSA-N
Therapeutic ✓ Yes
Active Moiety CHEMBL1201375

Known Names

AGN 190168 AGN-190168 AGN190168 Arazlo Avage Fabior Idp-123 Tazarotene Tazarotene component of duobrii Tazarotene component of idp-118 Tazaroteno Tazorac +1 more
4
Targets
7
Activities
2
Assay Types
0
PK Parameters
20
Publications
13
Known Names
9
Indications
1
Mechanisms

Molecular Properties

351.5
MW (Da)
4.43
ALogP
4
HBA
0
HBD
39.2
PSA (Ų)
0.59
QED
0
Ro5 Violations
2
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1997
Availability Prescription
Chirality Achiral

Routes of Administration

Topical

Flags

Natural Product Prodrug
USAN Stem -arotene
USAN Year 1994

Extended Properties

Molecular Formula C21H21NO2S
MW 351.47
Aromatic Rings 2
Heavy Atoms 25
NP-Likeness -0.65

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Retinoic acid receptor agonist AGONIST Retinoic acid receptor

Indications

Acne Vulgaris Hypopigmentation Lentigo Psoriasis Psoriasis Idiopathic Pulmonary Fibrosis Skin Diseases Skin Neoplasms Lymphoma, T-Cell, Cutaneous

ATC Classification

D05AX05
tazarotene
Level 1: DERMATOLOGICALS
Level 2: ANTIPSORIATICS

Activity Summary

EC50 6 meas. best 9.1
IC50 1 meas. best 5.5

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Retinoic acid receptor beta
CHEMBL2008
EC50 9.1 9.1 0.8 2
Retinoic acid receptor gamma
CHEMBL2003
EC50 7.4 7.4 40.0 2
Retinoic acid receptor alpha
CHEMBL2055
EC50 7.2 7.2 63.0 2
Cytochrome P450 3A4
CHEMBL340
IC50 5.5 5.5 3150.0 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
16472241 10.2174/1570163043334794 Hepatotoxicity 18
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
- 10.6019/CHEMBL4689842 HEK-293T 9
- 10.6019/CHEMBL4689842 U2OS 8
- 10.6019/CHEMBL4689842 Fibroblast 5
- 10.6019/CHEMBL5724696 TERT-RPE1 4
- 10.6019/CHEMBL4495565 SARS-CoV-2 4
37468498 10.1038/s41467-023-40064-9 Alpha-1A adrenergic receptor 3
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2A 3
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2B 2
37468498 10.1038/s41467-023-40064-9 Beta-2 adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 Gamma-aminobutyric acid receptor subunit alpha-1 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
- 10.6019/CHEMBL4651402 SARS-CoV-2 2
- 10.6019/CHEMBL4495564 Replicase polyprotein 1ab 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 1A 2
19058965 10.1016/j.bmcl.2008.11.040 Retinoic acid receptor alpha 2
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M2 2
37468498 10.1038/s41467-023-40064-9 Alpha-2A adrenergic receptor 2
19058965 10.1016/j.bmcl.2008.11.040 Retinoic acid receptor gamma 2

Data from ChEMBL 36 via Core Engine